# Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins

> **NCT02230163** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de la Guadeloupe** · enrollment: 40 (estimated)

## Conditions studied

- Chikungunya Virus Infection

## Interventions

- **BIOLOGICAL:** anti-CHIKV hyperimmune immunoglobulins

## Key facts

- **NCT ID:** NCT02230163
- **Lead sponsor:** Centre Hospitalier Universitaire de la Guadeloupe
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-10
- **Final completion:** 2016-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02230163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02230163, "Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02230163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*